Treatment

Vyxeos 44 MG / 100 MG Liposome Injection clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
Vyxeos® With Clofarabine for Pediatric AML
This study looks at a new combination of medicines, Vyxeos and clofarabine, for children and young adults aged 1 to 21 with acute myeloid leukaemia (AML) that has come back or hasn't responded to previous treatments.
For: Relapsed Pediatric AML · Refractory Pediatric AML
Austria · Denmark · Germany